Phase 1 Moderate-to-severe Atopic Dermatitis Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Phase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis Patients

Moderate-to-severe Atopic Dermatitis

TRex Bio, Inc.115 enrolled14 locationsNCT06934252

Recruiting

Phase 1Phase 2

A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis

Children and Adolescents With Moderate-to-severe Atopic Dermatitis

Guangdong Hengrui Pharmaceutical Co., Ltd50 enrolled1 locationNCT06713499